Contracts › 75N93024F00002
75N93024F00002: Model Development and Medical Counter Measures (MCMS) for Bsl-4 Agents in Nhps.
Awarded to University of Texas Medical Branch at Galveston by National Institutes of Health (NIH).
$3.3Mobligated
$6.7Mpotential value
17 January 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93024F00002 |
|---|---|
| Vehicle | HHSN272201700040I |
| Awardee | University of Texas Medical Branch at Galveston |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | TX |
| Offers received | 1 |
| Period of performance | 25 June 2024 to 17 January 2027 |
| Potential end | 24 June 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record